Capricor Therapeutics Inc (CAPR)

[Rogerthat1]

$CAPR Excellent results here on very low doses of mRNA ( 20 times smaller dose than expected to deliver to larger animals and Humans. Strong CD4+ and CD8+ TCell durable responses. This is what we needed to show to predict long term efficacy. As well TCell responses were seen for both S and N proteins. This next generation vaccine will replace the first generation which only targets S protein and generates mainly a humoral antibody response. N protein generates mainly a TCell response. We get the best of both worlds. Safety is also a Main factor for vaccine acceptance and it was met with flying colours. All IMO from my understanding. EXOSOMES based Vaccines and Drug Delivery Platform have now been officially validated. BO coming eventually. IMO